Literature DB >> 17303656

Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion.

Damian G Romero1, Licy L Yanes, Angela F de Rodriguez, Maria W Plonczynski, Bronwyn L Welsh, Jane F Reckelhoff, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez.   

Abstract

The differentiation of the adrenal cortex into functionally specific zones is probably due to differential temporal gene expression during fetal growth, development, and adulthood. In our search for adrenal zona glomerulosa-specific genes, we found that Disabled-2 (Dab2) is expressed in the zona glomerulosa of the rat adrenal gland using a combination of laser capture microdissection, mRNA amplification, cDNA microarray hybridization, and real-time RT-PCR. Dab2 is an alternative spliced mitogen-regulated phosphoprotein with features of an adaptor protein and functions in signal transduction, endocytosis, and tissue morphogenesis during embryonic development. We performed further studies to analyze adrenal Dab2 localization, regulation, and role in aldosterone secretion. We found that Dab2 is expressed in the zona glomerulosa and zona intermedia of the rat adrenal cortex. Low-salt diet treatment increased Dab2-long isoform expression at the mRNA and protein level in the rat adrenal gland, whereas high-salt diet treatment did not cause any significant modification. Angiotensin II infusion caused a transient increase in both Dab2 isoform mRNAs in the rat adrenal gland. Dab2 overexpression in H295R human adrenocortical cells caused an increase in aldosterone synthase expression and up-regulated aldosterone secretion under angiotensin II-stimulated conditions. In conclusion, Dab2 is an adrenal gland zona glomerulosa- and intermedia-expressed gene that is regulated by aldosterone secretagogues such as low-salt diet or angiotensin II and is involved in aldosterone synthase expression and aldosterone secretion. Dab2 may therefore be a modulator of aldosterone secretion and be involved in mineralocorticoid secretion abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303656     DOI: 10.1210/en.2006-1509

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  34 in total

Review 1.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

2.  Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis.

Authors:  Damian G Romero; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Physiol Genomics       Date:  2010-09-28       Impact factor: 3.107

3.  Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata.

Authors:  Koshiro Nishimoto; Christine S Rigsby; Tao Wang; Kuniaki Mukai; Celso E Gomez-Sanchez; William E Rainey; Tsugio Seki
Journal:  Endocrinology       Date:  2012-02-28       Impact factor: 4.736

Review 4.  Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.

Authors:  Teresa M Seccia; Brasilina Caroccia; Elise P Gomez-Sanchez; Paul-Emmanuel Vanderriele; Celso E Gomez-Sanchez; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

5.  Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?

Authors:  Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  Hypertension       Date:  2011-12-27       Impact factor: 10.190

6.  The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion.

Authors:  Marzia Scortegagna; Annabel Berthon; Nikolaos Settas; Andreas Giannakou; Guillermina Garcia; Jian-Liang Li; Brian James; Robert C Liddington; José G Vilches-Moure; Constantine A Stratakis; Ze'ev A Ronai
Journal:  JCI Insight       Date:  2017-12-07

7.  Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.

Authors:  Jana P Ball; Maryam Syed; Rodrigo O Marañon; Michael E Hall; Roshan Kc; Jane F Reckelhoff; Licy L Yanes Cardozo; Damian G Romero
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

8.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Carolina Velarde-Miranda; Maria W Plonczynski; C Richard Parker; William Rainey; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2013-12-08       Impact factor: 4.102

9.  Angiotensin II triggers expression of the adrenal gland zona glomerulosa-specific 3β-hydroxysteroid dehydrogenase isoenzyme through de novo protein synthesis of the orphan nuclear receptors NGFIB and NURR1.

Authors:  Takumi Ota; Masao Doi; Fumiyoshi Yamazaki; Daisuke Yarimizu; Kazuki Okada; Iori Murai; Hida Hayashi; Sumihiro Kunisue; Yuuki Nakagawa; Hitoshi Okamura
Journal:  Mol Cell Biol       Date:  2014-08-04       Impact factor: 4.272

Review 10.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.